Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Spontaneous mesenteric hematoma complicating an exacerbation of Crohn’s disease: report of a case

  • Hutan Ashrafian1, 2Email author,
  • James HR Manfield1,
  • Anuja Mitra1,
  • Derek J Boyle1 and
  • Pawan Mathur1
BMC Surgery201414:35

DOI: 10.1186/1471-2482-14-35

Received: 17 July 2013

Accepted: 27 May 2014

Published: 3 June 2014


Case Presentation

Spontaneous mesenteric haematoma is a rare condition that occurs due to localized bleeding in the mesenteric vascular tree of a bowel segment in the absence of an identifiable cause. Here we report a case of spontaneous mesenteric haematoma during an inflammatory exacerbation of Crohn’s disease. The patient underwent surgical management for small bowel obstruction secondary to Crohn’s disease, however the concurrent presence of a spontaneous mesenteric haematoma in the mid-jejunal mesentery was successfully managed conservatively.


This case identifies the first association of spontaneous mesenteric haematoma with an exacerbation of Crohn’s disease and highlights the need to consider rare differential diagnoses such as SMH when performing radiological assessment of unexplained symptoms in inflammatory bowel disease patients.


Crohn’s disease Mesenteric haematoma Inflammatory bowel disease Surgery


Spontaneous mesenteric haematoma (SMH) is a rare condition of unknown aetiology. It can be managed conservatively in the event that there is no associated mesenteric haemorrhage. It must be clinically distinguished from spontaneous mesenteric intraperitoneal haemorrhage (or abdominal apoplexy) where there is rupture or bleeding from a specific mesenteric vessel due to an unknown cause that typically requires urgent surgical management due to its high mortality. This report presents the first case in the literature associating SMH with an inflammatory exacerbation of Crohn’s disease.

Case presentation

A 44-year-old female presented with an exacerbation of Crohn’s disease that was not responsive to medical management with escalating steroid (prednisolone) and purine analogue (azathioprine) therapy. She was a non-smoker and aside from well-controlled essential hypertension had no other significant co-morbidities. Her inflammatory bowel disease had already required two previous hospitalizations, and she had suffered from symptoms of intermittent pain and bloating with constipation throughout the 12 months since her diagnosis. In the preceding month a computed tomography (CT) scan revealed 3 segments of Crohn’s disease strictures with prestenotic dilatation and an inflammatory appearance (Figure 1a). No mesenteric haematoma was identified at this point (Figure 1b). Blood tests taken at this time were unremarkable with a haemaglobin (Hb) of 11.7 g/dl, white cell count (WCC) of 5.4 × 109/L and a C-reactive protein (CRP) of 7 mg/L. Her symptoms initially resolved with intravenous hydrocortisone but promptly recurred with worsening malnutrition despite intensifying steroid therapy. She had not received any formal anticoagulation other than prophylactic subcutaneous low-molecular weight heparin (20 mg once daily) during the period of her hospitalization. Repeat CT scan (Figure 2) demonstrated a significant deterioration in small bowel dilatation with impending obstruction due to a 10 cm distal ileal stricture and a left upper quadrant abdominal ‘mass’ (9 × 12 × 20 cm), thought to be an inflammatory phlegmon secondary to an area of more proximal Crohn’s disease. Repeat blood tests at this time revealed anaemia with a haemaglobin of 8.6 g/dl, a normal WCC of 6.5 × 109/L and a CRP of 25 mg/L. No clotting abnormalities were identified and liver function tests were unremarkable.
Figure 1

Initial computed tomography (CT) scan demonstrating (a) Crohn’s strictures; (b) Absence of mesenteric haematoma.
Figure 2

Computed tomography (CT) scan demonstrating small bowel obstruction and mesenteric haematoma taken at the same anatomical level as Figure 1 b.

Subsequent laparotomy identified a grossly dilated segment of ileum proximal to a terminal ileal stricture. There was also a large haematoma within the mesentery of the mid-jejunum that corresponded to the mass demonstrated on CT (Figure 3). There was no evidence of local vascular trauma or pancreatico-biliary inflammation. The loop of jejenum was viable and macroscopically normal without any associated signs of Crohn’s disease. The remainder of the small and large bowel also appeared normal. The patient underwent a limited right hemicolectomy and double barrel stoma formation from the ileum and ascending colon. After surgery she was placed on an enhanced recovery protocol and was discharged on the 5th post-operative day. She is currently well and to date her follow-up has remained un-eventful.
Figure 3

Intraoperative image of mid-jejunal mesenteric haematoma.


The surgical complications of Crohn’s disease include bowel obstruction, fistulation, ulceration, anal fissures and cancer [1]. The pathological severity of this condition derives from a combination of inherited factors and environmental triggers that lead to gut inflammation and local microvascular ischaemia [2, 3]. The vascular component of Crohn’s disease has been primarily associated with arterial and venous thrombotic events that can lead to mesenteric ischaemia, venous congestion and bowel perforation [1, 4]. There is an association between patients with Crohn’s disease who suffer from intramural bowel haematomas, bleeding diatheses and anticoagulation therapy [5]. To the best of our knowledge, we report the first case in the literature of spontaneous jejunal mesenteric (mesojejunal) haematoma.

Spontaneous mesenteric haematoma (SMH) is a rare condition that occurs due to localized bleeding in the mesenteric vascular tree of a bowel segment with unknown aetiology [68]. It can be clinically distinguished from the related disease pathology of spontaneous mesenteric intraperitoneal haemorrhage (abdominal apoplexy) that occurs due to the spontaneous rupture of a specific mesenteric vessel likely from undiagnosed mesenteric arterial dissection and perivascular pseudo aneurysms. In these cases there is evidence of both intraperitoneal and retroperitoneal haemorrhage [9]. SMH can be managed conservatively [68] if there is no associated haemorrhage and although the patient in this case underwent surgery for intestinal stenosis, the concurrent mesenteric haematoma was successfully managed conservatively.

Patients with isolated SMH typically present with non-specific symptoms of generalised abdominal pain and as a result the haematoma is usually identified on imaging modalities such as CT. Although the cause is unknown, the disease process may be associated with unidentified anticoagulation mismanagement or even undiagnosed connective tissue disease [68].

Our case demonstrates the presence of localised mid-jejunal mesenteric fat haematoma. Localised visceral inflammation is a recognised contributor to confined microvascular bleeding [10] so that the inflammatory exacerbation of Crohn’s disease in this case may have resulted in severe mesenteric fat inflammation to initiate localised capillary leakage and subsequent haematoma.

Mesenteric fat has been recently recognised an essential location for the generation of Crohn’s gastrointestinal inflammation [11, 12]. Here bacterial translocation associated with immunoregulation through nucleotide-binding oligomerization domains (NOD1 and 2) and Toll-like receptors (TLRs 2 and 4) result in an increase in local inflammatory mediators including C-reactive-protein (CRP). The powerful inflammatory role of the bowel mesentery might be a contributory factor in the association between Crohn’s exacerbation and mesenteric haematoma in this case.

Our intraoperative findings of mesojejunal haematoma reflect the current underestimation of Crohn’s ileitis, demonstrating explicit involvement of the mesenteric fat with an associated mesenteric haematoma. This case also highlights how mesenteric abnormalities such as SMH may explain refractoriness or recurrence of symptoms despite intensifying steroid therapy. Indeed, it is possible that ileal compression caused by a mesenteric mass such as this may explain many of the symptoms accredited to Crohn’s strictures. As a result, we believe that an increased awareness of the role of the bowel mesentery may give new insights into Crohn’s disease pathogenesis. Furthermore, assessment for mesenteric abnormalities may guide future clinical and radiological assessment of unexplained symptoms in patients suffering form this multi-systemic inflammatory process, and identify rare differential diagnoses such as SMH.


We describe a case of spontaneous mesenteric haematoma in a female patient suffering from an exacerbation of Crohn’s disease and intestinal stenosis. The mesenteric haematoma was identifiable both on pre-operative computerised tomography and intra-operatively. This case identifies the first association of spontaneous mesenteric haematoma with an exacerbation of Crohn’s disease and highlights the need to consider rare differential diagnoses such as SMH when performing radiological assessment of unexplained symptoms in inflammatory bowel disease patients.


Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.



C-reactive protein


Toll-like receptor


Nucleotide-binding oligomerization domain


Spontaneous mesenteric haematoma


Computerized tomography.


Authors’ Affiliations

Department of General Surgery, Barnet Hospital, Barnet and Chase Farm Hospitals NHS Trust
Department of Surgery and Cancer, Imperial College London


  1. Gardiner KR, Dasari BV: Operative management of small bowel Crohn’s disease. Surg Clin North Am. 2007, 87 (3): 587-610. 10.1016/j.suc.2007.03.011.View ArticlePubMedGoogle Scholar
  2. Baumgart DC, Sandborn WJ: Crohn’s disease. Lancet. 2012, 380 (9853): 1590-1605. 10.1016/S0140-6736(12)60026-9.View ArticlePubMedGoogle Scholar
  3. Thornton M, Solomon MJ: Crohn’s disease: in defense of a microvascular aetiology. Int J Color Dis. 2002, 17 (5): 287-297. 10.1007/s00384-002-0408-5.View ArticleGoogle Scholar
  4. Ha C, Magowan S, Accortt NA, Chen J, Stone CD: Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009, 104 (6): 1445-1451. 10.1038/ajg.2009.81.View ArticlePubMedGoogle Scholar
  5. Abbas MA, Collins JM, Olden KW: Spontaneous intramural small-bowel hematoma: imaging findings and outcome. AJR Am J Roentgenol. 2002, 179 (6): 1389-1394. 10.2214/ajr.179.6.1791389.View ArticlePubMedGoogle Scholar
  6. Parker SG, Thompson JN: Spontaneous mesenteric haematoma; diagnosis and management. BMJ Case Rep. 2012, 2012: doi:10.1136/bcr-2012-006624. PMID: 22865811Google Scholar
  7. Gomez D, Rahman SH, Guillou PJ: Spontaneous mesenteric haematoma: a diagnostic challenge (On-line case report). Ann R Coll Surg Engl. 2006, 88: 1-3.View ArticleGoogle Scholar
  8. Ashley S: Spontaneous mesenteric haematoma and small bowel infarction complicating oral anticoagulant therapy. J R Soc Med. 1990, 83 (2): 116-PubMedPubMed CentralGoogle Scholar
  9. Cawyer JC, Stone CK: Abdominal apoplexy: a case report and review. Am J Emerg Med. 2011, 40 (3): e49-e52. 10.1016/j.jemermed.2007.11.080.View ArticleGoogle Scholar
  10. Whitcomb DC, Muddana V, Langmead CJ, Houghton FD, Guenther A, Eagon PK, Mayerle J, Aghdassi AA, Weiss FU, Evans A, Lamb J, Clermont G, Lerch MM, Papachristou GI: Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. AmJ Gastroenterol. 2010, 105 (10): 2287-2292. 10.1038/ajg.2010.183.View ArticleGoogle Scholar
  11. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, Beclin E, Odou MF, Neut C, Colombel JF, Desreumaux P: Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease. Gut. 2012, 61 (1): 78-85. 10.1136/gutjnl-2011-300370.View ArticlePubMedGoogle Scholar
  12. Siegmund B: Mesenteric fat in Crohn’s disease: the hot spot of inflammation?. Gut. 2012, 61 (1): 3-5. 10.1136/gutjnl-2011-301354.View ArticlePubMedGoogle Scholar
  13. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:


© Ashrafian et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.